Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells.
about
Maintenance of synaptic stability requires calcium-independent phospholipase A₂ activityNew findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutationsGenetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceTwo chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetesGene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal agingTgPL2, a patatin-like phospholipase domain-containing protein, is involved in the maintenance of apicoplast lipids homeostasis in ToxoplasmaMechanisms of brain iron transport: insight into neurodegeneration and CNS disorders.Group VIA phospholipase A2 mitigates palmitate-induced β-cell mitochondrial injury and apoptosisPLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease.Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils.Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.Rice phospholipase A superfamily: organization, phylogenetic and expression analysis during abiotic stresses and development.Expression of PLA2G6 in human fetal development: Implications for infantile neuroaxonal dystrophy.Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions.PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron.iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology.PLA2G6 mutation underlies infantile neuroaxonal dystrophyMolecular diagnosis of infantile Neuro axonal Dystrophy by Next Generation Sequencing.Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.PLA2G6-associated Dystonia-Parkinsonism: Case Report and Literature Review.Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex.Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2.Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells.On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation.Roles of acidic phospholipids and nucleotides in regulating membrane binding and activity of a calcium-independent phospholipase A2 isoformDeficiency of iPLA₂β Primes Immune Cells for Proinflammation: Potential Involvement in Age-Related Mesenteric Lymph Node LymphomaTwo unusual cases of PLA2G6-associated neurodegeneration from IndiaMultiple roles of phospholipase A2 during lung infection and inflammation.Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla.Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids.Tissue-specific differences in brain phosphodiesters in late-life major depressionSynthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes.Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides
P2860
Q27027705-2856B113-93ED-4346-8795-7C8CD21CDAFDQ27304506-033608F3-A189-4269-BCD7-FDFFDA9BEE5DQ28077356-25901325-0B7E-4A03-B8F9-EBC7EB12BC2EQ28474794-3DD6BA06-DC12-4613-BE02-7F63D25A9178Q28535466-4DC5271C-3DE4-44EA-ABF4-000A19F8BF2BQ28566224-A6198F93-C765-475F-A8BD-823AA3ADEA3EQ30044790-9BBC361D-08E5-40B5-BF08-7DE8E293F119Q33616799-5782FE42-D0CE-4C72-8BE6-B5014A84385FQ33619491-9F199957-0DE9-41FF-8AA2-BC3915263C0BQ33722781-26D8867B-B296-497E-ACC6-3CD8FAB04C19Q33761398-198EA22D-901F-48DF-BF7E-5B01A85B2C68Q33833653-E72230D1-B5FD-4586-8B13-332187C8BE12Q33867989-44747284-237F-4D68-ADFE-F4179D62C6E4Q33886495-A2A1A02C-ADE8-4222-A680-EA2AA3006E51Q34170369-963854FF-0DF6-4A77-9489-BF006354F07FQ34288560-A3D30011-7E50-4E87-A3B9-F97622C5F416Q34305395-81146C3C-7537-4ECE-BD6B-F45BCAC057E7Q34568479-3793AD10-067E-4F5E-837A-49D611FAEEFFQ35189288-E06497C0-1252-4873-A059-1E9045C15CA5Q35221441-48636EE0-82F2-470F-92A0-7B99412C6FE3Q35327810-3665AFE1-7D6A-424C-89E6-840336EB1669Q35847275-A0250C95-D913-46C4-856E-E3850ED4E385Q35856426-BFA5269F-0B66-4007-AB76-3ACC213DFF8FQ36022678-8A93C9FD-9E6B-4A07-9F8A-8930C11130EDQ36097167-991D751D-7A96-4D03-AA6B-46054F3EFF10Q36097195-AA3D51CB-014B-426D-9BE8-1081749C6B06Q36174271-3D203530-4FA9-45A5-AEB7-48BFF4E2ECBEQ36302173-D9960805-D2F0-44C3-861E-F87E55E67B02Q36381145-782D09D8-688F-4173-B48D-0225179BF389Q36385891-46DDE9A2-1619-4936-9F8D-FC4DFF15B0A2Q36416156-6C07FE6C-A5CA-4215-B57E-86D7A339F931Q36662848-180AE9EA-A64E-4129-803B-CAB0798F9E5DQ36710691-E07586C2-95B5-40A0-89C1-D4431417775BQ36728449-0BDA5B1E-4818-47D4-BBE9-256E7C8B285FQ36800670-F5B9474C-A5B1-41F1-945A-24F00FE039F9Q37077987-1B36075B-8F70-4146-B4DC-676004A33F4BQ37110292-7652B90E-8847-42ED-9647-E10FD92B652EQ37112089-6553D503-A541-4794-9C94-C5F23D895553Q37184050-279DB3A3-9CD2-4DD0-B78C-10E9330FB127Q37226101-63F93D5E-E088-4AA2-BB08-2611D57745CB
P2860
Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cellular regulation and propos ...... olipase A2 in activated cells.
@ast
Cellular regulation and propos ...... olipase A2 in activated cells.
@en
type
label
Cellular regulation and propos ...... olipase A2 in activated cells.
@ast
Cellular regulation and propos ...... olipase A2 in activated cells.
@en
prefLabel
Cellular regulation and propos ...... olipase A2 in activated cells.
@ast
Cellular regulation and propos ...... olipase A2 in activated cells.
@en
P1433
P1476
Cellular regulation and propos ...... olipase A2 in activated cells.
@en
P2093
Jesús Balsinde
María A Balboa
P304
P356
10.1016/J.CELLSIG.2005.03.002
P577
2005-04-07T00:00:00Z